Met Life Investment Management, LLC Acadia Pharmaceuticals Inc Transaction History

Met Life Investment Management, LLC

$17.1 Billion
Q3 2024

A detailed history of Met Life Investment Management, LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Met Life Investment Management, LLC holds 70,379 shares of ACAD stock, worth $1.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

70,379

Previous 70,379 -0.0%

Holding current value

$1.2 Million

Previous $1.14 Million 5.25%

% of portfolio

0.01%

Previous 0.01%

37 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$14.62 - $18.42 $96,842 - $122,014	6,624 Added 10.39%	70,379 $1.14 Million
Q1 2024 May 14, 2024	BUY	$17.79 - $30.86 $1.13 Million - $1.97 Million	63,755 New	63,755 $1.18 Million
Q2 2023 Apr 29, 2024	BUY	$17.8 - $25.65 $1.13 Million - $1.64 Million	63,755 New	63,755 $1.53 Million
Q1 2023 May 09, 2024	BUY	$16.32 - $20.92 $1.04 Million - $1.33 Million	63,755 New	63,755 $1.2 Billion
Q1 2023 May 15, 2023	SELL	$16.32 - $20.92 $42,366 - $54,308	-2,596 Reduced 3.91%	63,755 $1.2 Million
Q4 2022 Jun 14, 2023	BUY	$14.2 - $18.63 $36,863 - $48,363	2,596 Added 4.07%	66,351 $1.06 Million
Q3 2022 Jun 14, 2023	BUY	$14.11 - $18.27 $36,629 - $47,428	2,596 Added 4.07%	66,351 $1.09 Million
Q2 2022 Jun 20, 2023	BUY	$13.01 - $27.22 $33,773 - $70,663	2,596 Added 4.07%	66,351 $934,000
Q1 2022 May 10, 2024	BUY	$20.94 - $27.5 $1.39 Million - $1.82 Million	66,351 New	66,351 $1.61 Million
Q1 2022 Jun 20, 2023	BUY	$20.94 - $27.5 $54,360 - $71,390	2,596 Added 4.07%	66,351 $1.61 Million
Q1 2022 Mar 22, 2023	BUY	$20.94 - $27.5 $487,169 - $639,787	23,265 Added 54.0%	66,351 $1.61 Million
Q1 2022 May 12, 2022	BUY	$20.94 - $27.5 $487,169 - $639,787	23,265 Added 54.0%	66,351 $1.61 Million
Q4 2021 Jun 21, 2023	SELL	$16.79 - $27.09 $347,032 - $559,923	-20,669 Reduced 32.42%	43,086 $1.01 Million
Q3 2021 Jun 21, 2023	SELL	$15.78 - $24.77 $326,156 - $511,971	-20,669 Reduced 32.42%	43,086 $715,000
Q2 2021 May 17, 2024	SELL	$19.4 - $27.42 $400,978 - $566,743	-20,669 Reduced 32.42%	43,086 $1.05 Million
Q2 2021 Jun 21, 2023	SELL	$19.4 - $27.42 $400,978 - $566,743	-20,669 Reduced 32.42%	43,086 $1.05 Million
Q2 2021 Mar 22, 2023	SELL	$19.4 - $27.42 $98,687 - $139,485	-5,087 Reduced 10.56%	43,086 $1.05 Million
Q2 2021 Aug 16, 2021	BUY	$19.4 - $27.42 $835,868 - $1.18 Million	43,086 New	43,086 $1.05 Million
Q2 2020 Aug 14, 2020	SELL	$39.26 - $52.73 $1.89 Million - $2.54 Million	-48,173 Closed	0 $0
Q1 2020 Jul 12, 2023	SELL	$31.65 - $46.87 $493,170 - $730,328	-15,582 Reduced 24.44%	48,173 $2.04 Million
Q4 2019 Jul 12, 2023	SELL	$36.21 - $51.4 $564,224 - $800,914	-15,582 Reduced 24.44%	48,173 $2.06 Million
Q4 2019 Mar 22, 2023	BUY	$36.21 - $51.4 $74,773 - $106,141	2,065 Added 4.48%	48,173 $2.06 Million
Q4 2019 Feb 14, 2020	BUY	$36.21 - $51.4 $74,773 - $106,141	2,065 Added 4.48%	48,173 $2.06 Million
Q3 2019 Jul 12, 2023	SELL	$22.22 - $44.01 $392,116 - $776,644	-17,647 Reduced 27.68%	46,108 $1.66 Million
Q3 2019 Mar 22, 2023	SELL	$22.22 - $44.01 $79,169 - $156,807	-3,563 Reduced 7.17%	46,108 $1.66 Million
Q3 2019 Nov 14, 2019	SELL	$22.22 - $44.01 $79,169 - $156,807	-3,563 Reduced 7.17%	46,108 $1.66 Million
Q2 2019 Jul 12, 2023	SELL	$23.32 - $28.12 $328,438 - $396,042	-14,084 Reduced 22.09%	49,671 $1.33 Million
Q1 2019 Jul 13, 2023	SELL	$16.17 - $27.38 $227,738 - $385,619	-14,084 Reduced 22.09%	49,671 $1.33 Million
Q1 2019 Mar 22, 2023	BUY	$16.17 - $27.38 $62,286 - $105,467	3,852 Added 8.41%	49,671 $1.33 Million
Q1 2019 May 15, 2019	BUY	$16.17 - $27.38 $62,286 - $105,467	3,852 Added 8.41%	49,671 $1.33 Million
Q4 2018 Jul 13, 2023	SELL	$14.32 - $22.92 $256,843 - $411,093	-17,936 Reduced 28.13%	45,819 $740,000
Q4 2018 Mar 22, 2023	SELL	$14.32 - $22.92 $361,880 - $579,211	-25,271 Reduced 35.55%	45,819 $740,000
Q4 2018 Feb 14, 2019	SELL	$14.32 - $22.92 $361,880 - $579,211	-25,271 Reduced 35.55%	45,819 $741,000
Q3 2018 Jul 13, 2023	SELL	$13.03 - $21.81 $233,706 - $391,184	-17,936 Reduced 28.13%	45,819 $951,000
Q3 2018 Mar 22, 2023	BUY	$13.03 - $21.81 $61,749 - $103,357	4,739 Added 7.14%	71,090 $1.48 Million
Q3 2018 Nov 14, 2018	BUY	$13.03 - $21.81 $329,281 - $551,160	25,271 Added 55.15%	71,090 $1.48 Million
Q2 2018 Aug 15, 2018	BUY	$15.07 - $22.34 $690,492 - $1.02 Million	45,819 New	45,819 $700,000

Others Institutions Holding ACAD

# of Institutions

279

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account

Met Life Investment Management, LLC Acadia Pharmaceuticals Inc Transaction History